• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

    1.190 -0.470 (-28.31%)
    Streaming Delayed Price Updated: 2:42 PM EDT, Jul 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Nautilus Biotechnology, Inc. - Common Stock

    < Previous 1 2 3 Next >
    News headline image
    Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports First Quarter 2026 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Q1 Virtual Investor Summit Presentations Now Available On Demand
    Via ACCESS Newswire
    News headline image
    Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
    Via ACCESS Newswire
    News headline image
    Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
    Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
    Early Access Program participants receive exclusive use of Nautilus’ Iterative Mapping method, initially through a validated tau proteoforms assay, with the potential to accelerate Alzheimer’s and... 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
    Via ACCESS Newswire
    News headline image
    Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports First Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
    Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research’s esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.